New York, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Europe Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Gene sequencing, Drug Discovery, Companion Diagnostic, and Others); End-users (Diagnostic tool companies, Healthcare IT/ Big data companies, Pharma & Biotech companies, and Clinical Labs); and for Application (Oncology, CNS, Immunology, Respiratory and Others) – Europe Industry Analysis, Size, Share, Growth, Trends, and forecast 2014 – 2022”.
According to the report, Europe precision medicine market was valued at around USD 33,200.0 million in the year 2014 and it is expected to reach approximately USD 72,800.0 Million by 2022. The Europe precision medicine market is expected to exhibit a CAGR of more than 10.2% between 2017 and 2022.
The healthcare institutions in Europe are willing to use genetic testing and analytics technologies, payers willing to reimburse the cost of high-value drugs, drug companies that focus on developing new personalized therapies, companion diagnostics providers that drive improvements in information gathering, and genetic analytics services which help interpret the results. Considering all the above factors the market for precision medicines in Europe will significantly drive the market during the forecast period.
Browse through 24 Tables & 27 Figures spread over 110 Pages and in-depth TOC on "Global Europe Precision Medicine Market Size & Trends 2016: Industry Research, Growth Analysis & Forecast, 2022”.
Request Free Sample copy of Global Precision Medicine Market Report @ https://www.zionmarketresearch.com/sample/europe-precision-medicine-market
There will be an increasing demand for the Europe precision medicine market from the Diagnostic tool companies. Also, rising prevalence of cancer in the region will increase the preferences and tailors therapeutic interventions to the individual molecular features of a patient and/or their disease
The sector’s faster growth above the pharmaceutical industry is helped by the anticipated transition to more precision medicines, as well as the good growth within particular subsectors. Precision medicines contribute to the major segment of revenue in the pharmaceutical sector and are expected to continue during the forecast period.
There are several type technologies in precision medicines. The big data analytics segment is having a huge demand in the Europe precision medicine market owing to increased applications in the healthcare, and healthcare IT sectors. The role that big data analytics may have in interrogating the patient electronic health record toward improved clinical decision support, which will boost the segment in near future.
Due to the increase in awareness and high demand for diagnostic tools & instruments for targeted therapies, the diagnostic tool companies are dominating the Europe precision medicine market.
Browse the full "Europe Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Gene sequencing, Drug Discovery, Companion Diagnostic, and Others); End-users (Diagnostic tool companies, Healthcare IT/ Big data companies, Pharma & Biotech companies, and Clinical Labs); and for Application (Oncology, CNS, Immunology, Respiratory and Others) – Europe Industry Analysis, Size, Share, Growth, Trends, and forecast 2014 – 2022 " report at https://www.zionmarketresearch.com/report/data-quality-tools-market
Market Report Highlights:
- Increasing rate of severe diseases and raising awareness to prevent them will boost the precision medicines market throughout the forecast period
- The countries such as Germany and U.K are expected to experience a significant market growth with different kinds of solutions being offered and services being delivered. Moreover, in the last few years, countries such as Spain, France, and Germany have shown tremendous growth in precision medicine solution developments
- The rising concern of privacy is expected to restrict the growth of Europe precision medicine market
- Big data analytics dominates the technology segment of the Europe precision medicine market owing to increased applications in the healthcare, and healthcare IT sectors.
- The increasing awareness and use of targeted therapies for lethal diseases such as cancer require proper diagnostics. Hence the diagnostic tool companies are expected to acquire a major share of the market over the forecast period.
- Oncology dominates the Europe precision medicine market by applications. As cancer is among the leading causes of death, both nationally and worldwide. Precision medicine is particularly important in oncology, as it requires an in-depth understanding of the tumor biology of each patient.
- Many big players in precision medicine are involved in the process of innovating new products and technologies to promote and facilitate the growth of the precision medicine market.
According to the analysts and insights shared by industry experts during primary research, Healthcare IT/ Big data companies will be a business that will open up many opportunities for the Europe Precision Medicine market. As personalized healthcare has the capacity to detect the onset of a disease at its earliest stages, anticipate the progression of the disease and, at the same time, increase the efficiency of the health care system by improving quality, accessibility and affordability will increase the share of the healthcare IT in near future.
Ask The Analyst: https://www.zionmarketresearch.com/ask-to-analyst/europe-precision-medicine-market
Some of the prominent market players in the Europe Precision Medicine market include Roche, QIAGEN N.V., Cepheid, Inc, Johnson & Johnson Services, Inc., Illumina, Almac Group, bioMérieux SA, Intel Corporation, GE Healthcare, Novartis, Thermo Fisher Scientific, among others.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/europe-precision-medicine-market
Market Segmentation
Europe Precision Medicine Market: Technology Segment
Analysis
- Big Data Analytics
- Bioinformatics
- Gene sequencing
- Drug Discovery
- Companion Diagnostic
- Others
Europe Precision Medicine Market: End-user Segment
Analysis
- Diagnostic tool companies
- Healthcare IT/ Big data companies
- Pharma & Biotech companies
- Clinical Labs
Europe Precision Medicine Market: Application Segment
Analysis
- Oncology
- CNS
- Immunology
- Respiratory
- Other
Europe Precision Medicine Market: Country Segment Analysis
- Germany
- UK
- France
- Italy
- Spain
- Benelux
Related Reports:
- Immuno-oncology Therapy Market: https://www.zionmarketresearch.com/report/immuno-oncology-therapy-market
- Veterinary Anti-Infectives Market: https://www.zionmarketresearch.com/report/veterinary-anti-infectives-market
- Ingestible Smart Pills Market: https://www.zionmarketresearch.com/report/ingestible-smart-pills-market
- Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market: https://www.zionmarketresearch.com/report/enzyme-linked-immunosorbent-assay-testing-market
- Hepatitis C Drug Market: https://www.zionmarketresearch.com/report/hepatitis-c-drug-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research